The vital tube carries urine from the bladder and out through the urethral meatus during urination, and from the sperm s...
French company BioCorp has announced a partnership agreement with Danish pharmaceutical firm Novo Nordisk for the commer...
Sumitovant Biopharma, a wholly owned subsidiary of Japanese firm Sumitomo Pharma Co., and Switzerland & US-base...
Royal Philips has announced expanded rollout of its augmented reality (AR) surgical navigation solution - Clari...
Japan-based Astellas Pharma Inc. and Taysha Gene Therapies, Inc. have announced a strategic investment to support t...
Japan-based Olympus Corporation has announced that Stefan Kaufmann, the current Director, Executive Officer and Chief Ad...
Japanese pharmaceutical firm Takeda, and Germany-based Zedira and Dr. Falk Pharma GmbH have announced a collaborati...
Takara Bio USA, Inc., a pioneering life science reagent and instrument company and wholly owned subsidiary of Japan-base...
EditForce, headquartered in Fukuoka, Japan, has realized the world's first RNA-editing technology that enables RNA...
Indian firm Biocon Biologics has entered into a strategic out-licensing agreement with Japanese pharmaceuticals com...
Adragos Pharma, a rapidly growing pharmaceutical Contract Development and Manufacturing Organization (CDMO) base...
Fujifilm Corporation has announced that it will establish the company’s first Japanese Bio-CDMO (contract developm...
Israel-based medtech company CathWorks has announced the approval of the fourth generation CathWorks FFRangio Syste...
Olympus Corporation, a Japan-based medtech company, has announced the launch of EU-ME3, a new Endoscopic Ultrasound Proc...
Eisai has announced that as a part of the strategic investment towards the realization of its medium-term business plan ...
DentalMonitoring, the leading global provider of smart dentistry solutions, is setting foot in Japan to serve the Asian ...
Treatment of cancer using one’s own immune cells, natural killer (NK) cells and T-cells, called autologous immune ...
AstraZeneca’s Tezspire (tezepelumab) has been approved in Japan for the treatment of bronchial asthma in pati...
